Article Details

Pfizer says hemophilia gene therapy meets late-stage study goal | BioPharma Dive

Retrieved on: 2024-07-25 03:44:13

Tags for this article:

Click the tags to see associated articles and topics

Pfizer says hemophilia gene therapy meets late-stage study goal | BioPharma Dive. View article details on hiswai:

Excerpt

Dive Brief: An experimental gene therapy from Pfizer succeeded in a Phase 3 study of people with hemophilia A, overcoming safety concerns that had ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo